Ophthalmic formulation and method of manufacture thereof

Details for Australian Patent Application No. 2010313544 (hide)

Owner Inotek Pharmaceuticals Corporation

Inventors Avery, Kenneth L.; Takruri, Harun

Agent Inotek Pharmaceuticals Corporation

Pub. Number AU-A-2010313544

PCT Pub. Number WO2011/053569

Priority 61/254,923 26.10.09 US

Filing date 26 October 2010

Wipo publication date 5 May 2011

International Classifications

A61K 31/7076 (2006.01)

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

10 May 2012 PCT application entered the National Phase

  PCT publication WO2011/053569 Priority application(s): WO2011/053569

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010313550-Spirolactam derivatives and uses of same

2010313537-Absorbable polyethylene diglycolate copolymers to reduce microbial adhesion to medical devices and implants